SprinkleBit | Ginkgo Bioworks Holdings, Inc. (DNA)

Community actions

Ginkgo Bioworks Holdings, Inc. news

Ginkgo Bioworks Reports Third Quarter 2024 Financial Results
Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing
Ginkgo Bioworks Announces Date of Third Quarter 2024 Results Presentation
With 48% ownership, Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has piqued the interest of institutional investors
NOVUS Leverages Ginkgo Bioworks to Develop Innovative Feed Additives for Animal Agriculture
Ginkgo Bioworks Launches Ginkgo Datapoints to Transform AI Model Training in Biology
Ginkgo Bioworks Launches New Protein LLM and Model API Built on Google Cloud Technology
Ginkgo Regains Compliance with NYSE Minimum Bid Price Requirement
Ginkgo Bioworks Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
Upcoming Stock Splits This Week (August 19 to August 23) – Stay Invested
Ginkgo Bioworks Holdings Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Just Reported, And Analysts Assigned A US$1.11 Price Target

Recent Motivations

05 July, 3:59 PM EST/EDT	Open$0.37	Ask$0.35 x 0	P/E-0.51
DNA	Day$0.33 - $0.37	Bid$0.00 x 0	Dividend (Yield %)$0.00 (0.00%)
	52 Week$0.00 - $2.54	Volume360,781	US stocks data provided for free by IEX.
	Mkt. Cap.$545.94M	EPS0.00

Ginkgo Bioworks Holdings, Inc.